Director
CurrentPharmask is a global clinical trial masking company. Our proprietary technology is currently applied to a range of delivery routes including Metered Dose Inhalers, Nasal Devices and Injectables for several therapeutic areas including Pulmonary, the Central Nervous System and Vaccines. Every device is designed, and injection moulded, specifically for the delivery mechanism and offers many tangible advantages over traditional methods of masking, including the guarantee of total anonymity of drug product and extended shelf life.